Escherichia coli can be divided into 4 phylogroups: A, B1, B2 and D. Phylogroup B2 is associated with increased infection risk, and O25:ST131 specifically, is associated with increased virulence and extended-spectrum β-lactamase (ESBL)-production. We compared the prevalence of phylogroups and O25:ST131 in a collection of 108 wildtype E. coli and 134 ESBL-producing E. coli obtained from human rectal swabs, urine cultures and blood cultures. All isolates were obtained in our laboratory in a teaching hospital in the southern part of the Netherlands between 2010 and 2013. Phylogroup and O25:ST131-status was determined by real-time PCR, and ESBL-production was determined by double disk method according to the Dutch national guideline. The majority of isolates belonged to phylogroup B2 (56.6%). ESBL-producing E. coli were less likely to belong to this phylogroup (48.5%) than were wildtype E. coli isolates (66.7%; P=0.005). O25:ST131 E. coli were almost absent in phylogroup B2 wildtype E. coli (5.6%), while being abundant in ESBL-producing E. coli (61.5%;P<0.001). Phylogroups B2 and D wildtype E. coli were more prevalent among midstream urine isolates and human blood culture isolates, than in catheter related urine isolates (83.3% and 87.9% versus 61.9%; P=0.048). Our study supports the hypothesis that phylogroups B2 and D are more likely to cause infections than the other phylogroups, which need devices like urinary catheters to cause infection. Furthermore, O25:ST131 is significantly associated with ESBLproduction, and is almost absent among wildtype E. coli.
Statistical analysis
We hypothesise that all E. coli phylogroups can colonize the gut, but under normal circumstances only few will cause infection. In the case of indwelling catheters, we assume that virulence plays a minor role for E. coli variants to cause urinary tract infection, using the indwelling catheter to overcome the physiological barrier. This may be the case for both wildtype E. coli and for ESBL-producing E. coli, and should result in differences in prevalence of the four phylogroups and O25:ST131. Differences in prevalence of the different phylogroups were analysed by using the Chi-square test. Statistical significance was accepted if the chance for coincidence was less than 5%. All analyses were performed using the Statistical Package for Social Sciences software (SPSS, version 17).
Results
The collection consisted of 242 E. coli isolates of which 134 were ESBL-producing E. coli and 108 were wildtype E. coli. Thirty-eight ESBL-producing E. coli were obtained from human rectal swabs, 43 from midstream urine cultures, 19 from catheter-related urine cultures, and 34 from blood cultures. Fifty-four wildtype E. coli were obtained from human midstream urine cultures, 21 from catheter-related urine cultures, and 33 from blood cultures. Phylotyping PCR showed a positive result for phylotype A, B1, B2, and D in 40, 22, 137, and 43 of 242 isolates respectively. Using the real-time O25:ST131-specific PCR, the pathognomonic A and T SNPs were detected in 41 of 137 B2 isolates, and were absent 65 isolates. The O25:ST131 PCR showed inconclusive results for 31 (22.6%) of 137 B2 isolates. Of these 31 isolates with inconclusive results, sequence analysis of the pabB gene revealed the O25:ST131-specific A and T SNPs in 2 isolates (6.4%), and revealed absence of the pathognomonic SNPs in the other 29 isolates. Alignment of the pabB sequences revealed heterogeneity in the reverse primer positions used in the O25:ST131-specific A and T SNP real-time PCR which could explain the inconclusive results that were obtained for the non-O25:ST131 isolates. The majority of midstream urine isolates were from general-practitioners' patients (40 wildtype E. coli isolates; 74.1% and 34 ESBL-producing E. coli isolates; 79.1%) whereas all but one of catheter related urine isolates were obtained from hospitalized patients (95.2% of wildtype E. coli and 100% of ESBL-producing E. coli). All blood culture and rectal swab isolates were also obtained from hospitalized patients. Table 6 .1.1 shows the age and sex distribution of patients with E. coli from the different origins. Patients with indwelling catheters were significantly older than patients of which rectal swabs or midstream urine cultures were obtained (P=0.001 and P<0.001, respectively), and patients of which midstream urine cultures were obtained, were significantly younger than patients with indwelling catheters or with positive blood cultures (P<0.001 and 6.1
P<0.001).
This was the case for both ESBL-producing E. coli and for wildtype E. coli. For wildtype E. coli there was no association between phylogroup and age, whereas for ESBL-producing E. coli, patients with non-O25:ST131 phylogroup B2 E. coli were significantly younger than other patients (mean age of 41.4 vs. 67.1 years; P<0.001).
Patients with E. coli in midstream urine cultures were significantly more often female than the patients of which other cultures were obtained (P=0.001 for wildtype E. coli and P=0.008 for ESBL-producing E. coli). 19 They also found that phylogroup B2 was the predominant phylogroup in ESBL-producing E. coli, and O25:ST131 was the most prevalent clone. Furthermore, they also found phylogroup A to be more prevalent in ESBL-producing E. coli than in wildtype E. coli. Lee et al. also report the predominance of phylogroup B2 in E. coli from urine and blood culture samples. However, they also reported that phylogroup D was the dominant type in faecal samples, which is in contrast with the present study. This difference is probably caused by the fact that the bacterial collection analysed by Lee et al comprised mostly wildtype E. coli, whereas our faecal isolates were all ESBL-producing E. coli.
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The strength of real-time PCR for the phylotyping is the speed with which high numbers of isolates can be typed. Furthermore, this method is cost-efficient, easy to use and gives reliable results. These advantages were also true for the O25:ST131 specific realtime PCR, although this PCR showed some inconclusive results. The main limitation of our study is the fact that an O25:ST131-specific real-time PCR was used. Although O25:ST131 constitutes the majority of ST131 isolates, O16 is another serotype associated with equal virulence and ST131 status. 20, 21 Furthermore, the wildtype E. coli isolates from urine cultures were obtained prospectively, whereas the other isolates were part of a frozen collection. In addition, some isolates were missing from this collection. However, the absence of isolates occurred randomly and it is unlikely that this has influenced the results significantly.
In conclusion, our study supports the idea that E. coli colonizing the gut are not equally capable in causing infection. 
Abstract
The extended-spectrum β-lactamase (ESBL)-producing Escherichia coli clone O25:ST131 is pandemic in healthcare settings. The reasons for its success are unknown, but might include more effective transmission and/or longer persistence. Also, whether individuals differ for susceptibility to acquiring ESBL colonization remains unknown.
We evaluated an ongoing epidemic of colonization with ESBL-producing Enterobacteriaceae, including E. coli clone O25:ST131, in a long-term care facility (LTCF). During a 14-month-period, 6 repetitive prevalence surveys were performed, using ESBL-selective culture of rectal and faecal samples. Transmission rates, reproduction numbers, and duration of colonization were calculated and compared for ESBL-producing E. coli clone O25:ST131 and other E. coli isolates. Durations of colonization were compared using Kaplan-Meier survival analysis and the likely duration of the outbreak with ESBL-producing E. coli clone O25:ST131 was estimated using mathematical models. Three LTCF wards experienced a widespread, sustained outbreak with ESBL-producing E. coli clone O25:ST131, whereas 3 other wards experienced smaller, transient outbreaks involving other ESBL-producing strains. Transmission was plausible in 12 residents who acquired ESBL-producing E. coli clone O25:ST131 and 10 residents who acquired other strains. According to survival analysis, the half-life of carriage with ESBLproducing E. coli clone O25:ST131 was 13 months, versus 2-to-3 months for other strains (P<0.001). Per-admission reproduction numbers were 0.66 for ESBL-producing E. coli clone O25:ST131 versus 0.56 for other strains, predicting a mean time of 3-to-4 years for the outbreak strain(s) to disappear from the LTCF under current conditions. Transmissibility rates were comparable for ESBL-producing E. coli clone versus other ESBL-producing E. coli. Prolonged rectal carriage of the O25:ST131 clone explained the persistence of the outbreak. Effective decolonization strategies could have pronounced effects on outbreak duration.
Introduction
The worldwide prevalence of extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae is increasing rapidly. 1, 2 Infections with these and other resistant bacteria are associated with increased morbidity, mortality, and healthcare costs.
3,4
Enterobacteriaceae colonizing the gut are the most important reservoirs for infection 5 and can start an outbreak. 6 In the Netherlands, during cross-sectional measurements, approximately 5% of hospitalized patients were colonized with ESBL-producing Enterobacteriaceae. 7 Initially, outbreaks with ESBL-producing Enterobacteriaceae were hospital-associated. However, more and more outbreaks in long-term care facilities (LTCFs) are reported. 8, 9 Residents of LTCFs are mainly frail, elderly people, who often have medical devices and need medical attention. Among these resident, a low functional status, and thus more medical and nursing dependence, is associated with a greater risk of ESBL carriage.
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For their residents, LTCFs emphasize the quality of live, including participation in social activities, over healthcare. Therefore, the amount of interaction between LTCF residents is high in comparison with hospitalized patients, which may be important since the risk of transmission of ESBL-producing Enterobacteriaceae is greater among household contact than among hospital inpatients. 11 Furthermore, diagnostic sampling frequency in LTCFs is low and infection control measures are not as strict as in hospitals. We assume that, under these conditions, many outbreaks involving rectal carriage of ESBL are detected late or are overlooked. In June-July 2012, a routine prevalence survey involving 9 LTCFs in the southern Netherlands identified a facility with an unusually high prevalence of rectal ESBL carriage (21%). Typing showed the presence of one large cluster of ESBL-producing Escherichia coli from sequence type O25:ST131, along with other smaller clusters and unique strains. This prompted further investigations. The ESBL-producing Escherichia coli from the sequence type O25:ST131 lineage is a worldwide pandemic clone that is a major driver of the current worldwide spread of ESBLs. [12] [13] [14] This clone contains many virulence factors 15 and is associated with community-acquired infections. Older age and LTCF residence have been implicated as independent risk factors for colonization and infection with ESBL-producing E. coli of sequence type O25:ST131. 16 O25:ST131 was also the most prevalent clone in a recent study of antimicrobial resistance in another Dutch LTCF. 17 Here we evaluated the epidemiology of various ESBL-producing E. coli, including E. coli of sequence type O25:ST131, in a LTCF with an ongoing outbreak of ESBL. Specifically, we tested for inter-individual differences in susceptibility to acquiring ESBL-producing E. coli, and we assessed whether sequence type O25:ST131 strains were more transmissible or more persistent colonizers than other ESBL-producing E. coli, which are theoretical explanations for the pandemic success of this clone.
Methods Epidemiology
The LTCF comprises 4 semi-separate buildings (A, B, C, and D), each divided into 1-to-3 separate wards (A1-3, B1-2, C1-3 and D). Each ward housed approximately 20 residents and contained 2 kitchens and communal areas. Sanitary facilities were used communally by several residents. Staff members were dedicated to specific wards. The building contains communal recreation and therapy areas where residents from all buildings and wards meet regularly. During the study period, improved infection control measures, improved emphasis on hand hygiene, and improved cleaning strategies were implemented on all wards. No attempts were made to actively decolonize residents.
Specimen collection
During a 14-month period (March 2013 -April 2014), 6 cross-sectional surveys were performed by culturing faeces or rectal swabs from all residents. Residents admitted during the study were cultured similarly within 1 week after admittance.
To assess for different possible routes of transmission, concurrently with the resident surveys, environmental cultures were obtained 5 times, the hands of all available facility staff were cultured twice, residents' hands were cultured once, and air sedimentation cultures were collected twice near residents colonized with ESBL and near a selection of un-colonized residents.
Identification and detection of resistant strains
Faecal and rectal samples were collected using ESwab (Copan diagnostics, Brescia, Italy). ESwab was also used to culture residents' hands, emphasizing palms, fingers, nails, and jewellery. For air sedimentation cultures, 5 selective agar plates were placed around the selected residents when they were washing and dressing. Hand cultures were obtained from staff members by having the workers dip and rub their hands in tryptic soy broth (TSB) directly. For environmental cultures, standardized surfaces of 10x10cm were sampled thoroughly using ESwab medium in the first 2 surveys, and a sterile 10x10cm pad soaked in sterile isotonic saline solution for the next 3 surveys. The sterile pads used for environmental culturing and all ESwabs were incubated for 16-18h at 37°C in 15 ml of TSB containing 8 mg/l vancomycin and 0.25 mg/l cefotaxime. After incubation, 10 µl of the broth was inoculated on an EbSA agar plate (Cepheid Benelux, Ledeberg, Belgium), selective for ESBL-producing Enterobacteriaceae, which was incubated overnight. The TSB rinsates from staff members' hands were incubated directly, as were the agar plates used for air sedimentation culture.
6.2
Identification of all oxidase-negative, Gram-negative bacteria was performed by MALDI-TOF (bioMérieux, Marcy l'Etoile, France). Susceptibility testing was performed by VITEK2 (bioMérieux, Marcy l'Etoile, France), using EUCAST criteria, and ESBL production was confirmed by a double disk method. 
Statistical analysis
Acquisition was defined as detection of an ESBL-producing organism in a previously culture-negative resident. Transmission was defined as acquisition of an ESBLproducing E. coli strain identical according to AFLP profile and ESBL-variant to one already present on the ward where the subject resided prior to the acquisition. Routine prevalence surveys in several LTCFs and a hospital in the same area as the LTCF studied showed little clustering of ESBL-producing E. coli and low prevalence of colonization with O25:ST131 E. coli. Consequentially, it is unlikely for newly admitted residents to be colonized with the same strain as present on the ward they are admitted to. Therefore, transmission was also assumed for residents who were admitted during the study period, stayed on a ward over 14 days before being cultured, and when first cultured yielded an ESBL-producing E. coli strain already present on that ward. To identify inter-individual differences in susceptibility to acquiring colonization, we assessed whether there were differences between individuals in length of stay before being colonized. We reasoned that if difference in susceptibility are present, residents less susceptible to acquiring colonization should remain un-colonized for a longer length of stay than other residents. Length of stay was grouped into three-month periods in which residents could be ESBL-culture-negative and, consequentially, be at risk for acquisition, or have acquired ESBL-producing E. coli. The time for all ESBL-producing E. coli of sequence type O25:ST131 to disappear from the LTCF was estimated by using a mathematical model that incorporated the per-day transmission rate and a constant decolonization rate equal to the mean duration of colonization obtained from the Kaplan-Meier survival analysis. The model randomly simulated 1 million outbreaks. This was repeated for situations with 1-to-9 colonized residents per ward. Also, the effects on outbreak duration of alterations in the transmission rates and mean duration of colonization on outbreak duration were calculated.
Results

Colonization cultures
During the 14-month study period, the LTCF housed a total of 296 residents, 126 male and 170 female, with an average of 192 residents at the time of the prevalence surveys. During the study period, 125 residents were newly admitted and 120 residents were loss to follow up due to transfer to other facilities, transfer back home, or death. The average age at time of the prevalence surveys was 78 years (range: 46-98 years). The participation rate was 90.6% for intended culturing at the prevalence surveys and at admittance. Only 4 residents declined to participate at all culture points.
6.2
In total, 1050 rectal or faecal samples were obtained, of which 188 (17.9%) yielded one or more ESBL-producing E. coli isolates; 131 contained ESBL-producing E. coli of sequence type O25:ST131 and 57 contained other ESBL-producing E. coli isolates. The positive rectal samples were obtained from 69 individual residents (23.3%). Table 6 .2.1 shows the number of residents who were colonized at the start of the survey, acquired colonization during the study, or were already colonized when admitted during the study period. The prevalence of colonization with ESBL-producing E. coli was unequally distributed across the LTCF. At study onset, wards B-1, B-2, and C-2 had large clusters with ESBLproducing E. coli of sequence type O25:ST131 (29 carriers, all isolates from the same AFLP cluster; by-ward prevalence 39%-45%). Wards A-2, A-3, and C-3 had smaller clusters of other ESBL-producing E. coli plus sporadic carriage of non-related isolates (16 carriers; by-ward prevalence 11%-23%). The remaining 3 wards had only sporadic cases of ESBL-producing E. coli colonization (2 carriers; by-ward prevalence <5%). During the follow-up period, the outbreak with ESBL-producing E. coli of sequence type O25:ST131 continued, and a new outbreak of this clone occurred on ward A-3, whereas the outbreaks of other ESBL-producing E. coli disappeared over time. On wards C-1 and D, the prevalence of ESBL colonization remained nil. On ward A-1, a small increase in ESBL-producing E. coli colonization was observed in the last survey due to both 2 new introductions and 2 transmissions (Supplementary Figure S6. 2.1).
Environmental surveys
Of 485 standardized environmental cultures, 17 (3.5%) yielded ESBL-producing E. coli, including 17 (6.5%) of 263 done in the latter 3 surveys using the sterile gauze method, versus none (0%) done in the first 2 surveys using the ESwab method (P<0.001). Isolates 6.2 from only 9 (53%) of the 17 positive cultures matched isolates obtained from residents on the same ward during the same survey. Three identical environmental ESBLproducing E. coli isolates were obtained from ward D, but during the corresponding survey, a prevalence survey was nog performed on this ward. Toilets were the sites most likely to yield any ESBL-producing E. coli, and overall ESBL-producing E. coli of sequence type O25:ST131 were less often cultured than other ESBL-producing E. coli (Table 6 .2.2). 
Length of stay as protective factor
The risk of acquiring ESBL-producing E. coli remained stable for all lengths of stay, and prolonged length of stay did not select for residents less-susceptible to acquiring ESBLcolonization ( Figure 6.2.1 ). For both O25:ST131 E. coli and other ESBL-producing E. coli, acquisition risk did not differ between residents with a length of stay shorter than 12 months versus longer than 12 months (P=0.13 and P=0.84, respectively). Histogram shows the number of facility residents during the study period (Y-axis) with a length of stay equal or greater than the indicated number of months (X-axis). Blue, residents not colonized with ESBL-producing E. coli and therefore at risk for acquisition. Red, residents who acquired ESBL-producing E. coli during the indicated time period after admission. Residents already admitted at the start of our survey "entered" the histogram at moment of their first negative culture.
Duration of colonization
During the study, conversion to ESBL-negative was observed for 13 (33%) of 39 carriers with ESBL-producing E. coli of sequence type O25:ST131, versus 18 (62%) of 29 carriers with other ESBL-producing E. coli (P=0.03; residents acquiring colonization in the final prevalence survey were excluded). Survival analysis showed that the half-life of carriage for ESBL-producing E. coli of sequence type O25:ST131 was 13 months, compared to 2 to 3 months for other E. coli isolates (P<0.001; Figure 6 .2.2). 
Transmission rates
During the study, we documented 12 transmissions involving ESBL-producing E. coli of sequence type O25:ST131 and 10 involving other ESBL-producing E. coli. The ratio of per-day transmission rates for ESBL-producing E. coli of sequence type O25:ST131 versus other ESBL-producing E. coli was 0.59 (95% CI: 0.26-1.32), indicating that ESBLproducing E. coli spread as readily as ESBL-producing E. coli of sequence type O25:ST131. The corresponding reproduction numbers were 0.66 (95% CI 0.25-1.09) for ESBL-producing E. coli of sequence type O25:ST131 and 0.56 (95% CI 0.20-1.01) for other ESBL-producing E. coli. Figure S6 .2.2 show the estimated time for all ESBLproducing E. coli of sequence type O25:ST131 to disappear from a ward, given the number of colonized residents present, the mean duration of colonization, and the current reproduction numbers. A halving of the average length of colonization, e.g. by active decolonization, was predicted to reduce the expected duration of the outbreak twice as effectively as does halving the transmission rate, e.g. by improved hygiene. In the current situation, with a maximum of 6 colonized resident per ward, the mean expected time for all sequence type O25:ST131 ESBL-producing E. coli to disappear from the LTCF is >1000 days or 3-to-4 years. Halving the duration of colonization reduces the average expected time to approximately 400 days (1 year), versus 800 days (2-to-3 years) when the transmission rate is halved. Grey symbols: assume current conditions, without any change in tactics. Blue symbols: assume a 50% reduction of the transmission rate, e.g., by intensified infection control efforts. Red symbols: assume a 50% reduction in the duration of colonization, e.g., by active decolonization.
Discussion
We performed a prospective cohort study of ESBL colonization during an outbreak of intestinal colonization with various ESBL-producing E. coli, including ESBL-producing E. coli of sequence type O25:ST131, in a LTCF. In spite of the measures taken, the However, these differences were not statistically significant (P=0.10). Adler et al. found that CTX-M-27 (CTX-M-9 group)-producing E. coli of sequence type ST131 spread more efficiently than the CTX-M15 E. coli of sequence type ST131. 34 Since our cohort included only few CTX-M-9 group-positive O25:ST131 isolates, we could not reliably compare these two ST131 subgroups. Our analysis has several limitations. One is the underlying assumption that all residents are equally contagious over time, whereas, hypothetically, "super-spreaders" or periods of increased infectiousness may occur. Second, we used a conservative definition for "transmission" that presumed that transmission occurred only between residents on the same ward and disregarded the possibility of plasmid transmission. The resulting transmission number, which might have been underestimates, were used to calculate reproduction numbers, which if too low, could have resulted in underestimation of the average outbreak duration. On the other hand, the method used to type the isolates (AFLP) is not as detailed as, for example, whole genome sequencing. Theoretically this might have led to an overestimation of transmissibility by designating isolates to the same clonal complex which were actually different on whole genome sequencing. However, using AFLP in prevalence surveys in other healthcare facilities in the same area and time period, revealed hardly any clonal relatedness. Therefore, the clonal relatedness in this specific nursing home is likely to represent clonal spread. Another limitation is the setting, i.e. a specific LTCF, during an outbreak that had triggered intensified infection control measures. Transmission rates and duration of colonization might be different in other situations. However, we suspect that the differences in duration of colonization between ESBL-producing E. coli of sequence type O25:ST131 and other ESBL-producing E. coli can be extrapolated reasonably to other settings. Our study also had notable strengths. Most important is the length of follow-up with standardized intervals at which standardized cultures are taken, and the high participation rate.
In conclusion, we found that ESBL-producing E. coli of sequence type O25:ST131 can colonize residents for prolonged periods, with an estimated half-life of 13 months, 6 .2 which contrasts the half-life of 2-3 months for other ESBL-producing E. coli. Furthermore, calculated transmission rates did not differ between ESBL-producing E. coli of sequence type O25:ST131 and other ESBL-producing E. coli, and environmental contamination was more abundant for other ESBL-producing E. coli than for ESBL-producing E. coli of sequence type O25:ST131. Susceptibility was similar for residents with a shorter and longer length of stay. Duration of colonization was therefore the main identified factor contributing to the success of ESBL-producing E. coli of sequence type O25:ST131 in this LTCF. We postulate that prolonged colonization also may be the key to success of this clone worldwide. Our models predict that implementing additional infection control measures aimed at limiting the spread of ESBL-producing E. coli of sequence type O25:ST131 will only have a minor effect on outbreak duration whereas effective decolonization strategies should have a more profound effect. Therefore, in addition to implementing infection control measures, development of effective decolonization strategies is warranted to combat outbreaks like this worldwide. 
